Vioxx

A Free Service Provided By www.FactsOfLaw.com
Home

 

 

Legal Topics

Arbitration and Mediation
Bankruptcy
Bextra
Car Accidents
Celebrex
Child Support
Child Custody & Visitation

Copyright Law
Criminal Law
Dangerous Drugs
Death
Divorce
DUI Drunk Driving

Elderly Laws
Employees' Rights
Estate Planning
Family Law
Fen-Phen
Immigration Law

Lawsuits
Lemon Law
Marriage
Medical Malpractice
Megan's Law
Meridia
Mesothelioma & Asbestos

Mold
Probate & Estates
Product Recalls
Real Estate

Statute of Limitations

Taxes & the IRS
Traffic Violations
Vioxx
Wills
Workers' Compensation
Work Related Injury

Privacy Policy

Contact Us

About Us

 
Facts - Books - News    U.S. Facts Of Law:


Vioxx, FDA Health Advisory - Sept 30, 2004

On September 30, 2004, and FDA Health Advisory was issued announcing that Merck was announcing a voluntary withdrawal of Vioxx from the market due to safety concerns.  Vioxx was a commonly prescribed drug in the non-steroidal anti-inflammatory drug (NSAID) family.  It was approved by the FDA in 1999 for the management of pain and inflammation and was widely prescribed to arthritis sufferers.

A long term study of Vioxx on patients suffering from recurrent colon polyps was stopped early in September 2004 for safety reasons.  Subjects of the study using Vioxx showed an increased risk of heart attack and stroke compared to subjects taking a placebo.  Merck voluntarily pulled Vioxx from the market on September 30th.

 

Vioxx FDA Health Advisory Best Sellers from Amazon.com

(no title)

 

Newsfeed display by CaRP

Vioxx FDA Health Advisory News
GN News

This RSS Feed URL Is Deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Actemra Linked To Heart Attacks And Deaths, But Label Remains Unchanged Lawy...
Actemra Linked to Heart Attacks and Deaths, But Label Remains Unchanged LawyersandSettlements.com Washington, DC A recent presentation at the 2017 Annual Meeting of the American College of Rheumatology identified various factors that might predict the capacity for a patient suffering from rheumatoid arthritis RA to have success in tapering dosage

Failure To Warn: Hundreds Died While Taking An Arthritis Drug, But Nobody Ale...
STAT Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients STAT In 2008, when FDA scientific advisers met at a Silver Spring, Md., hotel near the agency39s headquarters to debate whether to recommend approval of Actemra, they were haunted by a notorious error just a few years earlier. Vioxx, another arthritis drug

Surprise Arthritis Drug Celebrex Shown As Safe As Ibuprofen And Naproxen Forbes
Forbes Surprise Arthritis Drug Celebrex Shown As Safe As Ibuprofen And Naproxen Forbes Merck immediately withdrew Vioxx from the market. However, the FDA was in a dilemma. Celebrex was still on the market and other COX 2 inhibitors were in late stage development. Was the increased cardiovascular CV risk seen unique to Vioxx, or did all 10 year study eases concerns about Celebrex, heart riskCNN Celebrex Is Found to Be No Riskier for Hearts Than Other Pain DrugsNew York Times Frequently Asked Questions FAQs Basics Arthritis CDC Centers for Disease Control and PreventionCenters for Disease Control and Prevention all 216 news articles raquo

Advisory Firm Urges Voting Against Mylan Board For Destroying Shareholder Val...
STAT Advisory firm urges voting against Mylan board for destroying shareholder value STAT n a damning report, a major shareholder advisory firm is recommending that Mylan stockholders vote to remove 10 incumbent board members including non executive chairman Robert Coury and chief executive officer Heather Bresch over the EpiPen and more raquo

IMPORTANT NOTICE: This webpage is Copyrighted content.  No portion of this page may be copied to any other webpage, forum, blog or other domain page or offline publication without written permission from FactsOfLaw.com. Violators will be prosecuted to the fullest extent of the law.

The information provided by FactsOfLaw.com does not constitute legal advice or any other type of advice and is provided for educational purposes only without warranty of any kind. FactsOfLaw.com has not reviewed the information on this page for accuracy and is not responsible for any errors, omissions or inaccuracies.  For legal advice you should consult a licensed attorney.

 

Copyright All Rights Reserved - FactsOfLaw.com
No Portion of This Page May Be Copied Without Written Permission

Facts of Law about the vioxx fda health advisory

Facts of Law - Vioxx FDA Health Advisory